Retinal Research Center
Current Studies
A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 gene therapy in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration
A Randomized, Partially Masked, Controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants with nAMD
A Randomized, Partially Masked, Controlled, Phase 2b/3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants with nAMD
A Long-term Follow-Up Study to Evaluate the Safety and Efficacy of RGX-314 Following Subretinal Administration in Participants with Neovascular Age-related Macular Degeneration and Fellow Eye Treatment Substudy
A Three-Part, Phase I Study to Investigate the Safety, Tolerability, Pharmacokinetics, And Efficacy of Zifibancimig Following Intravitreal Administration of Multiple Ascending Doses and Continuous Delivery from The Port Delivery in Patients with Neovascular Age-Related Macular Degeneration
A decentralized epidemiological study of the progression of Age-related Macular Degeneration (AMD), and a prospective epidemiological study of the progression of primary open-angle glaucoma and glaucoma subtypes
A Phase IV, Multicenter, Open-Label, Single-Arm Study to Investigate Faricimab (Ro6867461) Treatment Response in Treatment-Naïve, Underrepresented Patients with Diabetic Macular Edema
A Multicenter, Prospective, Observational Study of the Progression of Intermediate Age-Related Macular Degeneration
A Randomized, Participant and Investigator Masked, Placebo-Controlled, Multicenter, Proof-Of-Concept Study to Assess the Safety and Efficacy of LNP023 (Iptacopan) In Patients with Early and Intermediate Age-Related Macular Degeneration
A Long-Term Follow-Up Study to Evaluate the Safety of GT005 In Participants with Geographic Atrophy Secondary to Age-Related Macular Degeneration Treated in A Gyroscope-Sponsored Antecedent Study
A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of The Port Delivery System With Ranibizumab In Patients With Neovascular Age-Related Macular
For more information, please click to be redirected to the ClinicalTrials.gov page for each study. If you are interested in referring a patient for research, please contact the Research Center at (970) 828-4164 or researchreferrals@sweyeconsultants.com.
